• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Introduction of 2009 Pandemic Influenza A Virus Subtype H1N1 Into South Africa: Clinical Presentation, Epidemiology, and Transmissibility of the First

tetano

Editor, Senior Moderator
J Infect Dis. 2012 Dec;206 Suppl 1:S148-53. doi: 10.1093/infdis/jis583.
Introduction of 2009 Pandemic Influenza A Virus Subtype H1N1 Into South Africa: Clinical Presentation, Epidemiology, and Transmissibility of the First 100 Cases.
Archer BN, Timothy GA, Cohen C, Tempia S, Huma M, Blumberg L, Naidoo D, Cengimbo A, Schoub BD.
Source

National Institute for Communicable Diseases, National Health Laboratory Service.
Abstract

Background. We documented the introduction of 2009 pandemic influenza A virus subtype H1N1 (A[H1N1]pdm09) into South Africa and describe its clinical presentation, epidemiology, and transmissibility. Methods. We conducted a prospective descriptive study of the first 100 laboratory-confirmed cases of A(H1N1)pdm09 infections identified through active case finding and surveillance. Infected patients and the attending clinicians were interviewed, and close contacts were followed up to investigate household transmission. Findings. The first case was confirmed on 14 June 2009, and by 15 July 2009, 100 cases were diagnosed. Forty-two percent of patients reported international travel within 7 days prior to onset of illness. Patients ranged in age from 4 to 70 years (median age, 21.5 years). Seventeen percent of household contacts developed influenza-like illness, and 10% of household contacts had laboratory-confirmed A(H1N1)pdm09 infection. We found a mean serial interval (? SD) of 2.3 ? 1.3 days (range, 1-5 days) between successive laboratory-confirmed cases in the transmission chain. Conclusions. A(H1N1)pdm09 established itself rapidly in South Africa. Transmissibility of the virus was comparable to observations from outside of Africa and to seasonal influenza virus strains.

PMID:
23169962
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23169962
 
Back
Top Bottom